***IMPORTANT CASE UPDATE***
On December 21, 2022, residual distribution checks were mailed to Authorized Claimants who cashed their initial payment and were eligible to receive an additional payment under the Plan of Allocation. Please address any questions regarding your payment to the Claims Administrator.
The information contained on this web page is only a summary of information presented in more detail in the Notice of Pendency of Class Action, Proposed Settlement, and Motion for Attorneys’ Fees and Expenses (the “Notice”), which you can access by clicking here. Since this website is just a summary, you should review the Notice for additional details.
If you are a Settlement Class Member, your legal rights will be affected by this Settlement whether you act or do not act. Please read the Notice carefully
If you purchased or otherwise acquired the publicly traded common stock of PTC Therapeutics, Inc. during the period from November 6, 2014 to February 23, 2016, inclusive (the “Class Period”), and were allegedly damaged thereby, you may be entitled to a payment from a class action settlement.
| IMPORTANT DATES |
| CLAIM FILING DEADLINE: |
The deadline to submit a claim has passed. |
|
THE SETTLEMENT HEARING:
|
The Court held a final Settlement Hearing on September 7, 2018, and approved the Settlement, proposed Plan of Allocation and the motion requesting attorneys' fees and expenses. A copy of the order can be accessed on the Court Documents section. |
Please read the Notice carefully. If you have questions, you may call the PTC Therapeutics Securities Litigation Help Line at 877-242-4889 or email info@PTCTherapeuticsSecuritiesLitigation.com.